secwatch.observer — SEC 8-K summary
======================================

Issuer:     Longeveron Inc. (LGVN)
CIK:        0001721484
Form:       8-K
Filed at:   2024-04-18T23:59:59+00:00
Accession:  0001213900-24-034129
Event type: other_material
Sentiment:  positive
Materiality: 0.70
Item codes: 1.01, 3.02, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Longeveron raises $6.2M from warrant exercise, total $11.4M; regains Nasdaq compliance
--------------------------------------------------------------------------------

- Gross proceeds of ~$6.2M from exercise of 2,399,744 existing warrants at $2.35/share; combined with prior public offering totals ~$11.4M.
- Issued new unregistered warrants to purchase up to 4,799,488 shares (Series C: 5-year term, Series D: 24-month term, both at $2.35 exercise price).
- Intends to use net proceeds for clinical/regulatory development of Lomecel-B for HLHS, Alzheimer's, and general corporate purposes.
- Regained compliance with Nasdaq minimum bid price requirement after closing price >=$1.00 for 13 consecutive business days through April 15, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1721484/000121390024034129/0001213900-24-034129-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1721484/000121390024034129/ea0204043-8k_longeve.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-034129

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer